Skip to content

A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.

A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01925898
Enrollment
60
Registered
2013-08-20
Start date
2013-08-31
Completion date
2014-07-31
Last updated
2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacerations

Keywords

Laceration, Sedation, Pediatrics

Brief summary

Sedation is often needed for young children undergoing minor procedures in the emergency department (ED). Oral midazolam is one of the most commonly used regimens for children undergoing laceration repair but its sedative efficacy was shown to be suboptimal. In only one randomized controlled study oral ketamine has been used successfully for procedural sedation for laceration repair. A recent study showed that the combination of oral midazolam and oral ketamine provided deeper sedation compared with oral midazolam alone. However children treated wuth the combination of midazolam and ketamine required longer recovery Hypothesis: Oral ketamine can provide superior sedation to oral midazolam in children requiring sedation for laceration repair.

Interventions

DRUGMidazolam - active comparator

Oral midazolam - 0.7mg/kg single dose

DRUGExperimental Arm: Ketamine

Oral Ketamine 5mg/kg Single dose

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

• Any child with laceration requiring sedation

Exclusion criteria

* Major trauma * Closed head injury associated with loss of consciousness * Abnormal neurologic examination in a previously normal child * Significant developmental delay or baseline neurological deficit * A patient with seizures * Elevated intra-cranial pressure * Hypersensitivity to midazolam or ketamine * Hypertension * Hyperthyroidism or a patient receiving thyroid replacement * alcohol intoxication or a history of alcohol abuse * Acute or chronic respiratory, cardiac, renal or hepatic abnormalities * Glaucoma * Known psychiatric disease * American Society of Anesthesiologists (ASA) score of more than 2 * Informed consent cannot be obtained from legal guardian

Design outcomes

Primary

MeasureTime frameDescription
Pain score: Visual analog score (VAS)- by a parentDuring the procedure - up to 1 hourA parent will assess the child's pain on a Visual analog scale
Number of patients requiring IV sedationDuring the procedure - up to 1 hourpatients who fail to achieve University of Michigan Sedation Scale (UMSS) of two or higher will be switched to IV sedation

Secondary

MeasureTime frameDescription
Time to reach UMSS > 2up to 1 hour
• Procedure timeDuring the procedure - up to 1 hour
UMSS - by ED physicianDuring the procedure - up to 1 hour
The occurrence of adverse effects during the ED stayWhile in the ED - estimated time around 2 hoursSignificant adverse effects are defined as 1. Oxygen desaturation \<92% or hypoventilation requiering ventilatory support 2. Need for hemodynamic support 3. Anaphylaxis 4. Seizures 5. Any adverse effects requiring patient admission
• Patients and parents satisfaction assessed on VASWhile in the ED - estimated time around 2 hours
• Time from procedure to full recoveryWhile in the ED - estimated time around 2 hours
• VAS by nurseDuring the procedure - up to 1 hour

Countries

Israel

Contacts

Primary ContactEran Kozer, MD
erank@assaf.health.gov.il972-8-9779916

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026